Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

An estimated 30 million Americans have sleep apnea, which is defined as recurring episodes of partial or complete airway ...

Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...

More sleep apnea patients are turning to their dentist to get better rest, because some dentists are able to offer a ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.

In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...

Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Doctor Ian Newberrry with RI ENT and Brown University Health was instrumental in bringing it here to RI in 2024.

Just the same, readers are increasingly aware that even sleep comes with risks. Think sleep apnea. The throat muscles of some ...

DelveInsight’s, “Sleep Apnea Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 14+ pipeline drugs in Sleep Apnea pipeline landscape. It covers the Sleep Apnea ...